おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Receptos
company
About
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $30M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2007
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$85M
Receptos has raised a total of
$85M
in funding over 2 rounds. Their latest funding was raised on
Mar 27, 2013 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 27, 2013 | Series B | $30M | 1 | — | — | Detail |
| Mar 13, 2012 | Series Unknown | $30M | 1 | — | — | Detail |
| Nov 23, 2009 | Series A | $25M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Receptos is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
